Screening compound: ZSQDLAHDRWMHNO-SFHVURJKSA-N

Screening compound: ZSQDLAHDRWMHNO-SFHVURJKSA-N
Screening compound: ZSQDLAHDRWMHNO-SFHVURJKSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
ZSQDLAHDRWMHNO-SFHVURJKSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P681-0283

Molecular Formula

C18H22N2O2 (C18 H22 N2 O2)

Compound Name

1'-(cyclopentylcarbonyl)-1-methylspiro[indole-3,3'-pyrrolidin]-2(1H)-one

IUPAC name

1'-cyclopentanecarbonyl-1-methyl-12-dihydrospiro[indole-33'-pyrrolidin]-2-one

SMILES

CN(C(C1(CC2)CN2C(C2CCCC2)=O)=O)c2c1cccc2

MDL Number (MFCD)

ZSQDLAHDRWMHNO-SFHVURJKSA-N in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS MPO Library (28609 compounds)

GPCR Targeted Library (31838 compounds)

Hsp90-Targeted Library (11355 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Soluble Diversity Library (15920 compounds)

Spiro Library (21655 compounds)

Targeted Diversity Library (40567 compounds)

Akt-Targeted Library (14764 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with ZSQDLAHDRWMHNO-SFHVURJKSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound ZSQDLAHDRWMHNO-SFHVURJKSA-N?
Check Price and Availability of ZSQDLAHDRWMHNO-SFHVURJKSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of ZSQDLAHDRWMHNO-SFHVURJKSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for ZSQDLAHDRWMHNO-SFHVURJKSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for ZSQDLAHDRWMHNO-SFHVURJKSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of ZSQDLAHDRWMHNO-SFHVURJKSA-N available by request